Stay updated on Nivolumab Relatlimab Advanced Chordoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The Nivolumab and Relatlimab phase 2 study record for advanced chordoma is displayed, with details on participation criteria, interventions, measured outcomes, investigators, and study dates.
    Difference
    54%
    Check dated 2026-11-10T18:51:12.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T18:48:02.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study page, which still displays a 403 Forbidden error. The site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:09:20.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T19:51:07.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Access to the study record is now replaced by a 403 Forbidden page, indicating restricted access for this URL. The error page is displayed with the site header and footer instead of the trial details.
    Difference
    20%
    Check dated 2026-09-22T22:17:57.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0 on the page, reflecting a system or UI update. This change updates the page metadata without altering the study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-09-15T20:58:00.000Z thumbnail image

Stay in the know with updates to Nivolumab Relatlimab Advanced Chordoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page.